Document ID: chunk:federal_register_of_legislation:F2024C01228:reg:109
Version: federal_register_of_legislation:F2024C01228
Segment Type: reg
Provision Reference: reg 109
Character Range: 64194–65471

109   Vaccine                                                                                                                                                                                                                                                                                Prevenar           Injection (0.5mL)                                                                 Polysaccharides of Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F and 23F conjugated to diphtheria protein — 2 µg of each of serotypes 4, 9V, 14, 18C, 19F and 23F, and 4 µg of serotype 6B                                                                                                                                                        3 or 4 doses
      Pneumococcal (conjugate, 7‑valent)

      Circumstances
      Vaccine may be provided to:
       (a) a child who is about 2, 4 or 6 months old; or
       (b) a child who is about 12 months of age and is a member of a medical risk group; or
       (c) a person who is undergoing treatment, or will commence treatment, with Empavali (pegcetacoplan) for the treatment of adults with paroxysmal nocturnal haemoglobinuria who have an inadequate clinical response or are intolerant to treatment with eculizumab or ravulizumab.